Mohammadreza Shokouhimehr

Title: Innovations in MRI Contrast Agents by Mohammadreza Shokouhimehr

Introduction

Mohammadreza Shokouhimehr is an accomplished inventor based in Kent, OH (US). He has made significant contributions to the field of medical imaging, particularly in the development of MRI contrast agents. With a total of 2 patents, his work focuses on enhancing the safety and efficacy of imaging techniques used in clinical diagnosis.

Latest Patents

Shokouhimehr's latest patents include innovative materials and methods for MRI contrast agents and drug delivery. One of his notable inventions is a class of non-gadolinium and non-iron oxide based materials that utilize Prussian blue materials. These materials serve as T-weighted and/or T-weighted MRI contrast agents, which are beneficial for cellular imaging in both clinical diagnosis and biomedical research applications. The non-toxic agent can be internalized by cells through endocytosis, making it suitable for various medical imaging and drug delivery applications.

Another significant patent involves gadolinium (Gd) containing Prussian blue lattice contrast agents. These agents exhibit unexpectedly improved relaxivities, which are 1 or 2 magnitudes higher than commercial Gd-chelates. Additionally, they demonstrate low release of Gd ions into an aqueous environment, making them safe for clinical diagnosis when administered intravenously. The nanosize scale of the doped Prussian blue lattices ensures stability against agglomeration, further enhancing their utility in medical imaging.

Career Highlights

Shokouhimehr is affiliated with Kent State University, where he continues to advance research in medical imaging technologies. His work has garnered attention for its potential to improve patient outcomes through safer imaging techniques.

Collaborations

Some of his notable coworkers include Songping D Huang and Soumitra Basu, who contribute to the collaborative efforts in research and development within the field.

Conclusion

Mohammadreza Shokouhimehr's innovative work in MRI contrast agents represents a significant advancement in medical imaging technology. His contributions not only enhance imaging capabilities but also prioritize patient safety through the development of non-toxic materials.